Journal
VASCULAR PHARMACOLOGY
Volume 50, Issue 3-4, Pages 89-97Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.vph.2008.11.001
Keywords
Fura-2; Pulmonary arterial smooth muscle; Intracellular calcium; Ryanodine receptor; InsP(3) receptor
Categories
Funding
- NCRR (JRH) [HL49254, P20RR15518]
- SMW [HL10476, AI55462]
Ask authors/readers for more resources
Caffeine is a well described and characterized ryanodine receptor (RyR) activator. Previous evidence from independent research studies also indicate caffeine inhibits InsP(3) receptor functionality, which is important to activation of capacitative Ca2+ entry (CCE) in some cell types. In addition, RyR activation elicits excitatory-coupled Ca2+ entry (ECCE) in skeletal muscle myotubes. Recent studies by our group show that canine pulmonary arterial smooth muscle cells (PASMCs) have functional InsP(3) receptors as well as RyRs, and that CCE is dependent on InsP(3) receptor activity. The potential for caffeine to activate ECCE as well as inhibit InsP(3) receptor function and CCE was examined using fura-2 fluorescent imaging in canine PASMCs. The data show caffeine causes transient as well as sustained cytosolic Ca2+ increases, though this is not due to CCE or ECCE activity as evidenced by a lack of an increase in Mn2+ quench of fura-2. The experiments also show caffeine reversibly inhibits 5-HT elicited-InsP(3) mediated Ca2+ responses with an IC50 of 6.87 x 10(-4) M and 10 mM caffeine fully inhibits CCE. These studies provide the first evidence that caffeine is an inhibitor of InsP(3) generated Ca2+ signals and CCE in PASMCs. (c) 2008 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available